Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epilepsy | 68 | 2024 | 3310 | 6.670 |
Why?
|
Spasms, Infantile | 23 | 2023 | 305 | 4.460 |
Why?
|
Malformations of Cortical Development | 20 | 2022 | 200 | 3.840 |
Why?
|
Epilepsies, Partial | 14 | 2023 | 436 | 3.170 |
Why?
|
Seizures, Febrile | 6 | 2024 | 111 | 2.460 |
Why?
|
KCNQ2 Potassium Channel | 5 | 2023 | 24 | 1.950 |
Why?
|
Cerebral Palsy | 4 | 2024 | 459 | 1.550 |
Why?
|
Developmental Disabilities | 13 | 2021 | 1456 | 1.440 |
Why?
|
Mutation | 45 | 2023 | 29784 | 1.430 |
Why?
|
Epilepsy, Benign Neonatal | 3 | 2014 | 16 | 1.370 |
Why?
|
Sudden Infant Death | 5 | 2020 | 291 | 1.320 |
Why?
|
Epilepsy, Generalized | 8 | 2023 | 174 | 1.310 |
Why?
|
TOR Serine-Threonine Kinases | 10 | 2022 | 2108 | 1.180 |
Why?
|
Genetic Variation | 12 | 2022 | 6546 | 1.070 |
Why?
|
GTPase-Activating Proteins | 6 | 2019 | 498 | 1.020 |
Why?
|
Mitochondrial Membrane Transport Proteins | 3 | 2018 | 154 | 1.010 |
Why?
|
Cadherins | 6 | 2023 | 907 | 0.990 |
Why?
|
Seizures | 25 | 2023 | 2859 | 0.980 |
Why?
|
Zebrafish | 10 | 2022 | 2994 | 0.940 |
Why?
|
Sodium Channels | 3 | 2020 | 349 | 0.930 |
Why?
|
Anticonvulsants | 17 | 2023 | 1917 | 0.900 |
Why?
|
Microcephaly | 8 | 2022 | 432 | 0.860 |
Why?
|
Genetic Testing | 14 | 2022 | 3443 | 0.850 |
Why?
|
Infant | 61 | 2024 | 35129 | 0.820 |
Why?
|
Child, Preschool | 72 | 2023 | 40992 | 0.820 |
Why?
|
Brain Diseases | 8 | 2023 | 1564 | 0.810 |
Why?
|
Munc18 Proteins | 5 | 2022 | 29 | 0.810 |
Why?
|
Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2021 | 11 | 0.790 |
Why?
|
Dihydroorotase | 1 | 2021 | 11 | 0.790 |
Why?
|
Aspartate Carbamoyltransferase | 1 | 2021 | 22 | 0.780 |
Why?
|
Uridine | 1 | 2021 | 146 | 0.740 |
Why?
|
Genetic Predisposition to Disease | 20 | 2022 | 17449 | 0.740 |
Why?
|
Nerve Tissue Proteins | 8 | 2023 | 4465 | 0.710 |
Why?
|
Pedigree | 15 | 2021 | 4648 | 0.690 |
Why?
|
Pathology, Molecular | 1 | 2022 | 326 | 0.690 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 89 | 0.660 |
Why?
|
Information Management | 2 | 2018 | 98 | 0.660 |
Why?
|
Amino Acyl-tRNA Synthetases | 2 | 2017 | 93 | 0.660 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2019 | 126 | 0.650 |
Why?
|
Animal Husbandry | 1 | 2018 | 66 | 0.640 |
Why?
|
Death, Sudden | 4 | 2024 | 302 | 0.630 |
Why?
|
Phenotype | 33 | 2022 | 16365 | 0.620 |
Why?
|
Frameshift Mutation | 2 | 2020 | 399 | 0.610 |
Why?
|
Child | 71 | 2024 | 77679 | 0.600 |
Why?
|
Brain | 33 | 2023 | 26413 | 0.590 |
Why?
|
Mutation, Missense | 9 | 2023 | 2563 | 0.580 |
Why?
|
Sodium-Potassium-Chloride Symporters | 2 | 2016 | 102 | 0.580 |
Why?
|
Symporters | 3 | 2016 | 363 | 0.570 |
Why?
|
Periventricular Nodular Heterotopia | 5 | 2018 | 57 | 0.570 |
Why?
|
Vigabatrin | 3 | 2023 | 92 | 0.560 |
Why?
|
Quinidine | 2 | 2017 | 57 | 0.540 |
Why?
|
Trisomy | 4 | 2014 | 266 | 0.540 |
Why?
|
Cell Tracking | 1 | 2016 | 145 | 0.520 |
Why?
|
Repressor Proteins | 3 | 2018 | 3023 | 0.520 |
Why?
|
Mosaicism | 5 | 2023 | 441 | 0.520 |
Why?
|
Humans | 167 | 2024 | 744220 | 0.510 |
Why?
|
Electroencephalography | 28 | 2023 | 6150 | 0.510 |
Why?
|
DNA Copy Number Variations | 5 | 2022 | 1940 | 0.500 |
Why?
|
Status Epilepticus | 4 | 2023 | 444 | 0.470 |
Why?
|
Hemispherectomy | 1 | 2014 | 44 | 0.470 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 1080 | 0.470 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2014 | 658 | 0.460 |
Why?
|
Neurons | 12 | 2022 | 9335 | 0.460 |
Why?
|
Rett Syndrome | 1 | 2015 | 165 | 0.450 |
Why?
|
Neocortex | 3 | 2023 | 401 | 0.450 |
Why?
|
Phospholipase C beta | 1 | 2012 | 50 | 0.430 |
Why?
|
Male | 103 | 2023 | 350027 | 0.420 |
Why?
|
Nervous System Malformations | 2 | 2021 | 247 | 0.420 |
Why?
|
Cerebral Cortex | 9 | 2018 | 5709 | 0.410 |
Why?
|
Female | 101 | 2023 | 380197 | 0.410 |
Why?
|
Death, Sudden, Cardiac | 1 | 2020 | 1541 | 0.410 |
Why?
|
Movement Disorders | 3 | 2023 | 445 | 0.400 |
Why?
|
Chromosome Disorders | 1 | 2014 | 515 | 0.390 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2022 | 2503 | 0.390 |
Why?
|
Cerebrum | 1 | 2012 | 137 | 0.380 |
Why?
|
Genomic Structural Variation | 1 | 2011 | 65 | 0.380 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1199 | 0.360 |
Why?
|
Adolescent | 48 | 2022 | 85759 | 0.360 |
Why?
|
Potassium Channels | 4 | 2017 | 563 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2014 | 789 | 0.360 |
Why?
|
Gene Deletion | 3 | 2020 | 2751 | 0.360 |
Why?
|
Arthrogryposis | 1 | 2009 | 72 | 0.330 |
Why?
|
Genetic Association Studies | 6 | 2022 | 2702 | 0.330 |
Why?
|
Cell Lineage | 2 | 2017 | 2504 | 0.330 |
Why?
|
Spasm | 3 | 2023 | 121 | 0.330 |
Why?
|
Databases, Factual | 3 | 2022 | 7730 | 0.320 |
Why?
|
Age of Onset | 10 | 2021 | 3270 | 0.320 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2009 | 380 | 0.320 |
Why?
|
Dyskinesias | 2 | 2019 | 78 | 0.320 |
Why?
|
Microarray Analysis | 2 | 2022 | 766 | 0.320 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2023 | 648 | 0.310 |
Why?
|
Cerebellar Diseases | 2 | 2021 | 222 | 0.300 |
Why?
|
Albendazole | 1 | 2007 | 33 | 0.300 |
Why?
|
Antiparasitic Agents | 1 | 2007 | 41 | 0.290 |
Why?
|
Lissencephaly | 3 | 2016 | 38 | 0.290 |
Why?
|
Facies | 4 | 2020 | 197 | 0.280 |
Why?
|
Syndrome | 6 | 2019 | 3250 | 0.280 |
Why?
|
Triazoles | 4 | 2014 | 911 | 0.270 |
Why?
|
Young Adult | 30 | 2021 | 56436 | 0.270 |
Why?
|
Magnetic Resonance Imaging | 28 | 2020 | 35423 | 0.270 |
Why?
|
Synaptic Transmission | 4 | 2023 | 1179 | 0.270 |
Why?
|
Comparative Genomic Hybridization | 4 | 2021 | 496 | 0.270 |
Why?
|
Receptors, GABA-A | 3 | 2020 | 627 | 0.260 |
Why?
|
Neurogenesis | 1 | 2012 | 838 | 0.260 |
Why?
|
Animals | 34 | 2024 | 168788 | 0.260 |
Why?
|
Disease Models, Animal | 6 | 2020 | 18027 | 0.250 |
Why?
|
Functional Laterality | 3 | 2014 | 2290 | 0.250 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2020 | 895 | 0.250 |
Why?
|
Homocysteine | 1 | 2008 | 647 | 0.240 |
Why?
|
Neurology | 2 | 2023 | 764 | 0.240 |
Why?
|
Epilepsies, Myoclonic | 2 | 2021 | 80 | 0.240 |
Why?
|
Genotype | 12 | 2020 | 12956 | 0.240 |
Why?
|
Choristoma | 1 | 2005 | 213 | 0.230 |
Why?
|
Shab Potassium Channels | 2 | 2020 | 22 | 0.230 |
Why?
|
Cerebral Ventricles | 1 | 2005 | 544 | 0.220 |
Why?
|
Microtubule-Associated Proteins | 2 | 2018 | 1086 | 0.220 |
Why?
|
Tubulin | 2 | 2016 | 695 | 0.210 |
Why?
|
Cohort Studies | 18 | 2023 | 40559 | 0.210 |
Why?
|
Signal Transduction | 7 | 2019 | 23404 | 0.210 |
Why?
|
Fenfluramine | 1 | 2021 | 60 | 0.200 |
Why?
|
Ganglioglioma | 1 | 2021 | 42 | 0.200 |
Why?
|
Drosophila Proteins | 2 | 2024 | 1702 | 0.200 |
Why?
|
Autistic Disorder | 4 | 2019 | 1185 | 0.200 |
Why?
|
Pyrophosphatases | 1 | 2022 | 137 | 0.200 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2022 | 2938 | 0.200 |
Why?
|
Infant, Newborn | 16 | 2023 | 25618 | 0.200 |
Why?
|
Temporal Lobe | 2 | 2024 | 1670 | 0.200 |
Why?
|
Retrospective Studies | 28 | 2024 | 77426 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1518 | 0.190 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2022 | 2915 | 0.190 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2020 | 30 | 0.190 |
Why?
|
Genome, Human | 4 | 2022 | 4420 | 0.180 |
Why?
|
Siblings | 2 | 2023 | 854 | 0.180 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2019 | 26 | 0.180 |
Why?
|
Neural Inhibition | 2 | 2015 | 602 | 0.180 |
Why?
|
Adaptor Protein Complex mu Subunits | 1 | 2019 | 20 | 0.180 |
Why?
|
Chromosome Duplication | 1 | 2019 | 75 | 0.180 |
Why?
|
DNA Mutational Analysis | 5 | 2017 | 4188 | 0.170 |
Why?
|
Epilepsy, Frontal Lobe | 2 | 2010 | 26 | 0.170 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2019 | 43 | 0.170 |
Why?
|
Osteochondrodysplasias | 1 | 2021 | 183 | 0.170 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2023 | 403 | 0.170 |
Why?
|
Dicarboxylic Acid Transporters | 1 | 2018 | 5 | 0.170 |
Why?
|
Calcium Channels, N-Type | 1 | 2019 | 39 | 0.170 |
Why?
|
Speech Disorders | 1 | 2020 | 189 | 0.170 |
Why?
|
Calcium Channels, R-Type | 1 | 2018 | 14 | 0.170 |
Why?
|
Hippocampus | 5 | 2023 | 3676 | 0.170 |
Why?
|
Adult | 27 | 2024 | 214035 | 0.170 |
Why?
|
Neuropharmacology | 1 | 2018 | 21 | 0.170 |
Why?
|
Chorea | 2 | 2020 | 74 | 0.170 |
Why?
|
Fatal Outcome | 3 | 2019 | 1849 | 0.170 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 427 | 0.160 |
Why?
|
Carrier Proteins | 2 | 2017 | 5021 | 0.160 |
Why?
|
Language Development Disorders | 1 | 2020 | 196 | 0.160 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2019 | 326 | 0.160 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 142 | 0.160 |
Why?
|
Nervous System Diseases | 2 | 2023 | 1623 | 0.160 |
Why?
|
Larva | 2 | 2018 | 519 | 0.160 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2007 | 2017 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2020 | 449 | 0.150 |
Why?
|
Vision, Ocular | 1 | 2021 | 464 | 0.150 |
Why?
|
Clathrin | 1 | 2019 | 267 | 0.150 |
Why?
|
Chromosomes, Human | 1 | 2020 | 457 | 0.150 |
Why?
|
Sequence Analysis | 1 | 2018 | 256 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 2 | 2018 | 2848 | 0.150 |
Why?
|
Abnormalities, Multiple | 2 | 2019 | 1416 | 0.150 |
Why?
|
HLA-A Antigens | 1 | 2018 | 231 | 0.150 |
Why?
|
Vision Disorders | 2 | 2023 | 1059 | 0.150 |
Why?
|
Nephrosis | 1 | 2017 | 45 | 0.150 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 2 | 2014 | 13 | 0.150 |
Why?
|
Congenital Abnormalities | 1 | 2022 | 707 | 0.150 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 433 | 0.150 |
Why?
|
Telencephalon | 1 | 2017 | 143 | 0.150 |
Why?
|
Language Development | 1 | 2018 | 187 | 0.150 |
Why?
|
Search Engine | 1 | 2018 | 144 | 0.150 |
Why?
|
Academies and Institutes | 1 | 2019 | 317 | 0.150 |
Why?
|
Ataxia | 2 | 2020 | 304 | 0.150 |
Why?
|
Gliosis | 1 | 2017 | 245 | 0.140 |
Why?
|
Levodopa | 1 | 2017 | 219 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 655 | 0.140 |
Why?
|
Visual Pathways | 1 | 2021 | 565 | 0.140 |
Why?
|
Calcineurin | 1 | 2017 | 226 | 0.140 |
Why?
|
Hernia, Hiatal | 1 | 2017 | 79 | 0.140 |
Why?
|
Multigene Family | 1 | 2020 | 1102 | 0.140 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2018 | 440 | 0.140 |
Why?
|
Genetic Linkage | 2 | 2013 | 2422 | 0.140 |
Why?
|
Atrophy | 1 | 2021 | 1582 | 0.140 |
Why?
|
Contracture | 1 | 2018 | 223 | 0.140 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2015 | 11 | 0.140 |
Why?
|
Single-Cell Analysis | 3 | 2016 | 2183 | 0.140 |
Why?
|
Cation Transport Proteins | 1 | 2018 | 327 | 0.140 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2016 | 136 | 0.130 |
Why?
|
Pyrroline Carboxylate Reductases | 1 | 2015 | 6 | 0.130 |
Why?
|
Homozygote | 3 | 2021 | 1786 | 0.130 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2016 | 144 | 0.130 |
Why?
|
Brain Edema | 2 | 2018 | 617 | 0.130 |
Why?
|
Angelman Syndrome | 1 | 2017 | 136 | 0.130 |
Why?
|
Amino Acid Transport Systems, Acidic | 1 | 2015 | 28 | 0.130 |
Why?
|
Vesicular Transport Proteins | 1 | 2018 | 377 | 0.130 |
Why?
|
Tetrasomy | 1 | 2014 | 2 | 0.130 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 1 | 2015 | 39 | 0.130 |
Why?
|
Body Dysmorphic Disorders | 1 | 2018 | 229 | 0.130 |
Why?
|
Alopecia | 1 | 2018 | 381 | 0.120 |
Why?
|
Rare Diseases | 1 | 2019 | 553 | 0.120 |
Why?
|
PTEN Phosphohydrolase | 1 | 2020 | 1143 | 0.120 |
Why?
|
Cataract | 1 | 2021 | 834 | 0.120 |
Why?
|
Sturge-Weber Syndrome | 1 | 2015 | 91 | 0.120 |
Why?
|
Endocytosis | 1 | 2019 | 985 | 0.120 |
Why?
|
Multiprotein Complexes | 2 | 2018 | 1119 | 0.120 |
Why?
|
Nuclear Proteins | 2 | 2019 | 5853 | 0.120 |
Why?
|
Psychomotor Disorders | 1 | 2015 | 152 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2022 | 3598 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2023 | 63119 | 0.120 |
Why?
|
Genome-Wide Association Study | 5 | 2020 | 12264 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1854 | 0.120 |
Why?
|
Hemiplegia | 1 | 2014 | 135 | 0.120 |
Why?
|
Patch-Clamp Techniques | 4 | 2020 | 964 | 0.120 |
Why?
|
Entorhinal Cortex | 1 | 1995 | 272 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1028 | 0.120 |
Why?
|
Antiporters | 1 | 2015 | 277 | 0.120 |
Why?
|
Follow-Up Studies | 9 | 2018 | 39045 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 945 | 0.120 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2015 | 191 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 2017 | 970 | 0.110 |
Why?
|
Neuropsychological Tests | 4 | 2019 | 6991 | 0.110 |
Why?
|
Ocular Motility Disorders | 1 | 2014 | 135 | 0.110 |
Why?
|
Chromosome Aberrations | 2 | 2011 | 1814 | 0.110 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1655 | 0.110 |
Why?
|
Cerebral Veins | 1 | 1994 | 156 | 0.110 |
Why?
|
Sleep | 2 | 2022 | 4623 | 0.110 |
Why?
|
Narcolepsy | 1 | 2015 | 195 | 0.110 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2014 | 194 | 0.110 |
Why?
|
Chlorides | 1 | 2015 | 667 | 0.110 |
Why?
|
Disclosure | 1 | 2018 | 736 | 0.110 |
Why?
|
Neuropeptides | 1 | 2018 | 942 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2024 | 2916 | 0.100 |
Why?
|
Genes, Duplicate | 1 | 2012 | 33 | 0.100 |
Why?
|
Neurofibrillary Tangles | 1 | 1994 | 439 | 0.100 |
Why?
|
Consanguinity | 1 | 2013 | 456 | 0.100 |
Why?
|
Cerebral Arteries | 1 | 1994 | 494 | 0.100 |
Why?
|
Sequence Analysis, DNA | 5 | 2017 | 4803 | 0.100 |
Why?
|
Lateral Ventricles | 1 | 2012 | 146 | 0.100 |
Why?
|
HEK293 Cells | 5 | 2019 | 4201 | 0.100 |
Why?
|
Mitochondrial Diseases | 1 | 2015 | 321 | 0.100 |
Why?
|
Twins, Monozygotic | 1 | 2013 | 458 | 0.100 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2015 | 581 | 0.100 |
Why?
|
Caudate Nucleus | 1 | 2012 | 393 | 0.100 |
Why?
|
Diseases in Twins | 1 | 2013 | 450 | 0.100 |
Why?
|
Dyssomnias | 1 | 2010 | 29 | 0.100 |
Why?
|
Nerve Degeneration | 1 | 1995 | 748 | 0.100 |
Why?
|
Videotape Recording | 1 | 2012 | 350 | 0.090 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6274 | 0.090 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2014 | 372 | 0.090 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2012 | 338 | 0.090 |
Why?
|
Sodium Channel Blockers | 2 | 2022 | 176 | 0.090 |
Why?
|
Gene Dosage | 2 | 2017 | 1251 | 0.090 |
Why?
|
Astrocytes | 1 | 2017 | 1270 | 0.090 |
Why?
|
Immunity, Innate | 1 | 2022 | 2958 | 0.090 |
Why?
|
Child Development | 2 | 2019 | 2223 | 0.090 |
Why?
|
Encephalitis | 1 | 2013 | 423 | 0.090 |
Why?
|
Microtubules | 1 | 2015 | 1091 | 0.090 |
Why?
|
Sequence Homology | 2 | 2020 | 203 | 0.090 |
Why?
|
Amino Acid Sequence | 5 | 2019 | 13817 | 0.080 |
Why?
|
Drug Utilization | 1 | 2015 | 1183 | 0.080 |
Why?
|
SOXB1 Transcription Factors | 1 | 2010 | 284 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2019 | 14556 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2014 | 867 | 0.080 |
Why?
|
Calcium | 2 | 2019 | 5757 | 0.080 |
Why?
|
Electrodes, Implanted | 1 | 2013 | 824 | 0.080 |
Why?
|
Drugs, Investigational | 2 | 2021 | 214 | 0.080 |
Why?
|
Drosophila melanogaster | 1 | 2017 | 1708 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 1994 | 1438 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3921 | 0.080 |
Why?
|
Nocturnal Paroxysmal Dystonia | 1 | 2007 | 3 | 0.080 |
Why?
|
Pediatrics | 2 | 2022 | 3469 | 0.080 |
Why?
|
Alleles | 4 | 2024 | 6938 | 0.080 |
Why?
|
Autopsy | 3 | 2020 | 1021 | 0.080 |
Why?
|
Pentylenetetrazole | 2 | 2018 | 69 | 0.080 |
Why?
|
Benzodiazepines | 1 | 2014 | 1101 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.080 |
Why?
|
Hypertension | 1 | 2008 | 8480 | 0.080 |
Why?
|
RNA | 1 | 2018 | 2749 | 0.080 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2013 | 960 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 374 | 0.070 |
Why?
|
Microsatellite Repeats | 1 | 2009 | 802 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 1860 | 0.070 |
Why?
|
INDEL Mutation | 2 | 2018 | 279 | 0.070 |
Why?
|
Carbamazepine | 1 | 2007 | 229 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3646 | 0.070 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 284 | 0.070 |
Why?
|
Animals, Genetically Modified | 2 | 2024 | 1549 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9647 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13280 | 0.070 |
Why?
|
Neurocysticercosis | 1 | 2007 | 62 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2015 | 2586 | 0.070 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2022 | 890 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3063 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2019 | 21752 | 0.070 |
Why?
|
Health Resources | 1 | 2012 | 911 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1018 | 0.060 |
Why?
|
Research Design | 2 | 2018 | 5987 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3567 | 0.060 |
Why?
|
Electrophysiological Phenomena | 2 | 2016 | 315 | 0.060 |
Why?
|
Reoperation | 1 | 2014 | 4203 | 0.060 |
Why?
|
Oocytes | 2 | 2020 | 1187 | 0.060 |
Why?
|
Gene Duplication | 2 | 2020 | 330 | 0.060 |
Why?
|
Molecular Structure | 2 | 2018 | 1907 | 0.060 |
Why?
|
Tuberous Sclerosis | 1 | 2012 | 1029 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2684 | 0.060 |
Why?
|
Prognosis | 5 | 2022 | 29050 | 0.060 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2014 | 245 | 0.060 |
Why?
|
Brain Mapping | 1 | 2018 | 6671 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2305 | 0.060 |
Why?
|
Failure to Thrive | 1 | 2023 | 136 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2011 | 7879 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2727 | 0.050 |
Why?
|
Ontario | 1 | 2023 | 383 | 0.050 |
Why?
|
Inosine Triphosphate | 1 | 2022 | 2 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5722 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 2023 | 165 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8090 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2003 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1240 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2023 | 331 | 0.050 |
Why?
|
Connexins | 1 | 2023 | 360 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2024 | 473 | 0.050 |
Why?
|
Synapses | 2 | 2023 | 1729 | 0.050 |
Why?
|
Athetosis | 1 | 2020 | 16 | 0.050 |
Why?
|
Prospective Studies | 3 | 2021 | 53280 | 0.050 |
Why?
|
Heterozygote | 2 | 2018 | 2805 | 0.050 |
Why?
|
Nerve Net | 1 | 2013 | 2175 | 0.050 |
Why?
|
Amyloid beta-Peptides | 1 | 1994 | 3585 | 0.050 |
Why?
|
Inosine | 1 | 2022 | 133 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9582 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2422 | 0.050 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 297 | 0.050 |
Why?
|
Mouth Mucosa | 1 | 2023 | 434 | 0.050 |
Why?
|
Dextromethorphan | 1 | 2020 | 38 | 0.050 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2022 | 214 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2021 | 8860 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15538 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2022 | 389 | 0.050 |
Why?
|
Inpatients | 1 | 2012 | 2518 | 0.050 |
Why?
|
Zebrafish Proteins | 2 | 2017 | 1004 | 0.040 |
Why?
|
Memantine | 1 | 2020 | 100 | 0.040 |
Why?
|
Societies | 1 | 2020 | 104 | 0.040 |
Why?
|
Mice | 7 | 2020 | 81178 | 0.040 |
Why?
|
Genes, Lethal | 1 | 2019 | 242 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 418 | 0.040 |
Why?
|
Convulsants | 1 | 2018 | 70 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.040 |
Why?
|
Family | 1 | 2009 | 3148 | 0.040 |
Why?
|
DNA | 2 | 2008 | 7303 | 0.040 |
Why?
|
Macaca mulatta | 2 | 1995 | 2378 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2023 | 1284 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9438 | 0.040 |
Why?
|
Ferrets | 1 | 2018 | 194 | 0.040 |
Why?
|
Cricetulus | 1 | 2019 | 817 | 0.040 |
Why?
|
Dystonia | 1 | 2020 | 363 | 0.040 |
Why?
|
Brugada Syndrome | 1 | 2018 | 97 | 0.040 |
Why?
|
Potassium Channel Blockers | 1 | 2017 | 171 | 0.040 |
Why?
|
Models, Molecular | 2 | 2017 | 5458 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 20123 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4328 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2019 | 643 | 0.040 |
Why?
|
Gene Expression | 2 | 2020 | 7799 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 173 | 0.040 |
Why?
|
CHO Cells | 1 | 2019 | 1407 | 0.040 |
Why?
|
Semantics | 1 | 2020 | 584 | 0.040 |
Why?
|
Xenopus laevis | 1 | 2020 | 957 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2019 | 684 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.040 |
Why?
|
Organ Size | 2 | 2012 | 2252 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1246 | 0.030 |
Why?
|
Drosophila | 1 | 2024 | 1491 | 0.030 |
Why?
|
Cross Reactions | 1 | 2018 | 841 | 0.030 |
Why?
|
Middle Aged | 7 | 2023 | 213367 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 19227 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 2017 | 293 | 0.030 |
Why?
|
Cricetinae | 1 | 2019 | 2472 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 2017 | 396 | 0.030 |
Why?
|
Xenopus | 1 | 2017 | 712 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5216 | 0.030 |
Why?
|
Channelopathies | 1 | 2015 | 32 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6601 | 0.030 |
Why?
|
Aging | 1 | 1994 | 8661 | 0.030 |
Why?
|
Microelectrodes | 1 | 2016 | 303 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2505 | 0.030 |
Why?
|
Dendrites | 1 | 2017 | 485 | 0.030 |
Why?
|
Genes, Dominant | 1 | 2017 | 880 | 0.030 |
Why?
|
RNA, Transfer | 1 | 2017 | 316 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6757 | 0.030 |
Why?
|
Aminoacylation | 1 | 2014 | 10 | 0.030 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2015 | 105 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 809 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2017 | 1137 | 0.030 |
Why?
|
Denervation | 1 | 1995 | 278 | 0.030 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2017 | 436 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1590 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2019 | 1169 | 0.030 |
Why?
|
Mutagenesis | 1 | 2018 | 1267 | 0.030 |
Why?
|
Nephrotic Syndrome | 1 | 2017 | 389 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5076 | 0.030 |
Why?
|
Podocytes | 1 | 2017 | 396 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1782 | 0.030 |
Why?
|
History, 21st Century | 1 | 2019 | 1534 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1372 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1548 | 0.030 |
Why?
|
Cisterna Magna | 1 | 2012 | 41 | 0.030 |
Why?
|
Forensic Pathology | 1 | 2012 | 27 | 0.030 |
Why?
|
Hallucinations | 1 | 2015 | 360 | 0.030 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2013 | 117 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2803 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23337 | 0.030 |
Why?
|
Genetic Research | 1 | 2013 | 174 | 0.030 |
Why?
|
Prone Position | 1 | 2013 | 194 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2017 | 1185 | 0.030 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2013 | 171 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1682 | 0.030 |
Why?
|
Radiography | 2 | 2013 | 7022 | 0.030 |
Why?
|
Sirolimus | 1 | 2019 | 1563 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3133 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 72280 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2015 | 600 | 0.020 |
Why?
|
Vertebral Artery | 1 | 2012 | 192 | 0.020 |
Why?
|
Drug Discovery | 1 | 2019 | 1058 | 0.020 |
Why?
|
Ubiquitin | 1 | 2016 | 852 | 0.020 |
Why?
|
History, 20th Century | 1 | 2019 | 2739 | 0.020 |
Why?
|
Septo-Optic Dysplasia | 1 | 2010 | 9 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 635 | 0.020 |
Why?
|
Base Sequence | 2 | 2010 | 12801 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3461 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12207 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2575 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8321 | 0.020 |
Why?
|
Receptors, GABA | 1 | 2012 | 288 | 0.020 |
Why?
|
Apolipoprotein E4 | 1 | 1994 | 668 | 0.020 |
Why?
|
Rats | 2 | 2019 | 24273 | 0.020 |
Why?
|
Respiration Disorders | 1 | 2013 | 371 | 0.020 |
Why?
|
Basal Ganglia | 1 | 2012 | 545 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15525 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2017 | 1881 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11368 | 0.020 |
Why?
|
Protein Conformation | 1 | 2017 | 4012 | 0.020 |
Why?
|
Cobblestone Lissencephaly | 1 | 2008 | 3 | 0.020 |
Why?
|
Gestational Age | 1 | 2018 | 3493 | 0.020 |
Why?
|
Action Potentials | 1 | 2016 | 1815 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.020 |
Why?
|
Video Recording | 1 | 2013 | 947 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8302 | 0.020 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 615 | 0.020 |
Why?
|
Middle East | 1 | 2008 | 219 | 0.020 |
Why?
|
DNA Repair | 1 | 2017 | 2046 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
Fever | 1 | 2015 | 1614 | 0.020 |
Why?
|
Probability | 1 | 2013 | 2505 | 0.020 |
Why?
|
Corpus Callosum | 1 | 2012 | 737 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Models, Genetic | 1 | 2017 | 3494 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3523 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14726 | 0.020 |
Why?
|
Demography | 1 | 2012 | 1656 | 0.020 |
Why?
|
Hypothalamus | 1 | 2012 | 1063 | 0.020 |
Why?
|
Thalamus | 1 | 2012 | 1024 | 0.020 |
Why?
|
Lymphocytes | 1 | 2014 | 2617 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6765 | 0.020 |
Why?
|
Eye Abnormalities | 1 | 2008 | 246 | 0.020 |
Why?
|
Muscular Dystrophies | 1 | 2008 | 393 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10387 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4363 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2012 | 13990 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2013 | 978 | 0.020 |
Why?
|
Fetus | 1 | 2012 | 1880 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1994 | 6172 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6461 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2019 | 13036 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5180 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12244 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6196 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6485 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 2008 | 1401 | 0.010 |
Why?
|
Cause of Death | 1 | 2013 | 3584 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2616 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10949 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 12075 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9728 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 18116 | 0.010 |
Why?
|
Chronic Disease | 1 | 1995 | 9147 | 0.010 |
Why?
|
United States | 2 | 2019 | 69867 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12961 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8950 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 19907 | 0.010 |
Why?
|
Hospitalization | 1 | 2012 | 10262 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40063 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25043 | 0.010 |
Why?
|
Aged | 2 | 2012 | 163253 | 0.010 |
Why?
|